In Vivo Detection of Lymph Nodes Metastasis of ESCC Using CXCR4-Targeted Tracer [64Cu]Cu-NOTA-CP01

Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12:31–46

Article  PubMed  CAS  Google Scholar 

Kelty CJ, Kennedy CW, Falk GL (2010) Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma. J Thorac Oncol 5:1467–1471

Article  PubMed  Google Scholar 

Vazquez-Sequeiros E, Wiersema MJ, Clain JE et al (2003) Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterol 125:1626–1635

Article  Google Scholar 

Hosch SB, Stoecklein NH, Pichlmeier U et al (2001) Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 19:1970–1975

Article  PubMed  CAS  Google Scholar 

Sugawara K, Yamashita H, Seto Y (2020) Optimal definition of Nodal Skip Metastasis in patients with esophageal squamous cell carcinoma. Ann Thorac Surg 110:754

Article  PubMed  Google Scholar 

Li Y, Diao F, Shi S et al (2018) Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer. Chin J Cancer 37:3

Article  PubMed  PubMed Central  Google Scholar 

Ou X, Zhu J, Qu Y et al (2021) Imaging features of sentinel lymph node mapped by multidetector-row computed tomography lymphography in predicting axillary lymph node metastasis. BMC Med Imaging 21:193

Article  PubMed  PubMed Central  Google Scholar 

Rowe SP, Pomper MG (2022) Molecular imaging in oncology: current impact and future directions. CA Cancer J Clin 72:333–352

Article  PubMed  Google Scholar 

Todate Y, Honda M, Takada T et al (2021) The additional diagnostic impact of positron emission tomography-computed tomography for lymph node metastasis from colorectal cancer: a prospective lymph node level analysis. J Surg Oncol 124:1085–1090

Article  PubMed  CAS  Google Scholar 

Chen H, Pang Y, Wu J et al (2020) Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging 47:1820–1832

Article  PubMed  Google Scholar 

Pang Y, Zhao L, Luo Z et al (2021) Comparison of (68)Ga-FAPI and (18)F-FDG uptake in gastric, duodenal, and colorectal cancers. Radiol 298:393–402

Article  Google Scholar 

Chen S, Chen Z, Zou G et al (2022) Accurate preoperative staging with [(68)Ga]Ga-FAPI PET/CT for patients with oral squamous cell carcinoma: a comparison to 2-[(18)F]FDG PET/CT. Eur Radiol 32:6070–6079

Article  PubMed  CAS  Google Scholar 

Wu B, Chien EY, Mol CD et al (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Sci 330:1066–1071

Article  CAS  Google Scholar 

Cambier S, Gouwy M, Proost P (2023) The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cell Mol Immunol 20:217–251

Article  PubMed  PubMed Central  CAS  Google Scholar 

Heidegger I, Fotakis G, Offermann A et al (2022) Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer. Mol Cancer 21:132

Article  PubMed  PubMed Central  CAS  Google Scholar 

Neve Polimeno M, Ierano C, D’Alterio C et al (2015) CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not. Cell Mol Immunol 12:474–482

Article  PubMed  CAS  Google Scholar 

Kim J, Takeuchi H, Lam ST et al (2005) Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 23:2744–2753

Article  PubMed  CAS  Google Scholar 

Lu CL, Guo J, Gu J et al (2014) CXCR4 heterogeneous expression in esophageal squamous cell cancer and stronger metastatic potential with CXCR4-positive cancer cells. Dis Esophagus 27:294–302

Article  PubMed  Google Scholar 

Yang X, Lu Q, Xu Y, Liu C, Sun Q (2020) Clinicopathologic significance of CXCR4 expressions in patients with esophageal squamous cell carcinoma. Pathol Res Pract 216:152787

Article  PubMed  CAS  Google Scholar 

Goto M, Liu M (2020) Chemokines and their receptors as biomarkers in esophageal cancer. Esophagus 17:113–121

Article  PubMed  Google Scholar 

Kaifi JT, Yekebas EF, Schurr P et al (2005) Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst 97:1840–1847

Article  PubMed  CAS  Google Scholar 

Fang HY, Munch NS, Schottelius M et al (2018) CXCR4 is a potential target for diagnostic PET/CT Imaging in Barrett’s dysplasia and esophageal adenocarcinoma. Clin Cancer Res 24:1048–1061

Article  PubMed  CAS  Google Scholar 

Linde P, Baues C, Wegen S et al (2021) Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach. Cancer Imaging 21:22

Article  PubMed  PubMed Central  Google Scholar 

Peng T, Wang X, Li Z et al (2021) Preclinical evaluation of [(64)Cu]NOTA-CP01 as a PET imaging Agent for metastatic esophageal squamous cell carcinoma. Mol Pharm 18:3638–3648

Article  PubMed  CAS  Google Scholar 

Peng SB, Van Horn RD, Yin T et al (2017) Distinct mobilization of leukocytes and hematopoietic stem cells by CXCR4 peptide antagonist LY2510924 and monoclonal antibody LY2624587. Oncotarget 8:94619–94634

Article  PubMed  PubMed Central  Google Scholar 

Hamai Y, Emi M, Ibuki Y et al (2021) Distribution of Lymph Node Metastasis in Esophageal squamous cell Carcinoma after Trimodal Therapy. Ann Surg Oncol 28:1798–1807

Article  PubMed  Google Scholar 

Wang H, Deng F, Liu Q, Ma Y (2017) Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma. Pathol Res Pract 213:842–847

Article  PubMed  Google Scholar 

Shang Q, Zhao L, Pang Y, Yu Y, Chen H (2022) 68Ga-FAPI PET/CT distinguishes the reactive lymph nodes from Tumor Metastatic Lymph nodes in a patient with nasopharyngeal carcinoma. Clin Nucl Med 47:367–368

Article  PubMed  Google Scholar 

Song BI, Lee SW, Jeong SY et al (2012) 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer. J Nucl Med 53:1337–1344

Article  PubMed  CAS  Google Scholar 

Long J, Luo G, Liu C et al (2012) Development of a unique mouse model for pancreatic cancer lymphatic metastasis. Int J Oncol 41:1662–1668

Article  PubMed  CAS  Google Scholar 

Cho JW, Choi SC, Jang JY et al (2014) Lymph Node Metastases in Esophageal Carcinoma: an Endoscopist’s View. Clin Endosc 47:523–529

Article  PubMed  PubMed Central  Google Scholar 

Bailly C, Bodet-Milin C, Bourgeois M et al (2019) Exploring Tumor Heterogeneity using PET imaging: the big picture. Cancers (Basel) 11(9):1282

Article  PubMed  CAS  Google Scholar 

Tixier F, Vriens D, Cheze-Le Rest C et al (2016) Comparison of Tumor Uptake Heterogeneity characterization between Static and Parametric 18F-FDG PET images in Non-small Cell Lung Cancer. J Nucl Med 57:1033–1039

Article  PubMed  CAS 

留言 (0)

沒有登入
gif